Skip to main content
. 2021 Jun 23;224(8):1305–1315. doi: 10.1093/infdis/jiab333

Figure 6.

Figure 6.

Enhancement of anti-HKU1 S1-RBD and anti-OC43 S1 antibody levels following COVID-19 suggests cross-reactive antibody memory response. Anti-HCoV (HKU1 S1-RBD, NL63 S1-RBD, OC43 S1, and 229E S1-RBD) antibody titers were compared between post–COVID-19 (n = 16) and prepandemic samples from children (n = 50) and adults (n = 67). Horizontal bars represent geometric mean antibody titer in each group. *P < .05, ***P < .001, ****P < .0001. Abbreviations: COVID-19, coronavirus disease 2019; HCoV, human coronavirus; IgG, immunoglobulin G; NS, not significant; RBD, receptor-binding domain; S, spike.